Tom Nolan reviews this week’s research Critics argue that limited dosing options for polypills mean patients get suboptimal ...
Two new pressurised metered dose inhalers (pMDIs) with lower carbon emissions have been approved by the UK’s drug regulator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results